Your search returned 7 results.

Results
	1.	Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn's Disease. [electronic resource] by Vande Casteele, Niels Mould, Diane R Coarse, Jason Hasan, Iram Gils, Ann Feagan, Brian Sandborn, William J Producer: 20180628 In: Clinical pharmacokinetics vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Early remission status predicts long-term outcomes in patients with Crohn's disease treated with certolizumab pegol. [electronic resource] by Melmed, Gil Y McGovern, Dermot Schreiber, Stefan Kosutic, Gordana Spearman, Marshall Coarse, Jason Sandborn, William J Producer: 20170905 In: Current medical research and opinion vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials. [electronic resource] by Loftus, Edward V Colombel, Jean-Frederic Schreiber, Stefan Randall, Charles W Regueiro, Miguel Ali, Tauseef Arendt, Catherine Coarse, Jason Spearman, Marshall Kosutic, Gordana Producer: 20170809 In: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. [electronic resource] by van der Heijde, Désirée Gensler, Lianne S Deodhar, Atul Baraliakos, Xenofon Poddubnyy, Denis Kivitz, Alan Farmer, Mary Katherine Baeten, Dominique Goldammer, Nadine Coarse, Jason Oortgiesen, Marga Dougados, Maxime Producer: 20200707 In: Annals of the rheumatic diseases vol. 79 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease. [electronic resource] by Sandborn, William J Wolf, Douglas C Kosutic, Gordana Parker, Gerry Schreiber, Stefan Lee, Scott D Abraham, Bincy Afzali, Anita Arsenescu, Razvan I Gutierrez, Alexandra Spearman, Marshall Coarse, Jason Feagan, Brian G Producer: 20180424 In: Inflammatory bowel diseases vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial. [electronic resource] by Ritchlin, Christopher T Kavanaugh, Arthur Merola, Joseph F Schett, Georg Scher, Jose U Warren, Richard B Gottlieb, Alice B Assudani, Deepak Bedford-Rice, Kathy Coarse, Jason Ink, Barbara McInnes, Iain B Producer: 20200303 In: Lancet (London, England) vol. 395 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study. [electronic resource] by Lee, Scott D Rubin, David T Sandborn, William J Randall, Charles Younes, Ziad Schreiber, Stefan Schwartz, David A Burakoff, Robert Binion, David Dassopoulos, Themos Arsenescu, Razvan Gutierrez, Alexandra Scherl, Ellen Kayhan, Cem Hasan, Iram Kosutic, Gordana Spearman, Marshall Sen, David Coarse, Jason Hanauer, Stephen Producer: 20180202 In: Inflammatory bowel diseases vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)